The biodegradable nanoparticles could be topically applied to the skin or injected into the body to treat MRSA skin infections.
IBM Research – Almaden Advanced Organic Materials scientist James Hedrick said their combined materials development and bioengineering expertise enabled them to discover a new way to potentially treat infectious diseases.
IBN executive director Jackie Ying said this exciting platform technology can make a significant impact on the treatment of multidrug-resistant bacteria.